Page 855 - Small Animal Internal Medicine, 6th Edition
P. 855

CHAPTER 49   Disorders of the Endocrine Pancreas   827


            Less potent      Insulin detemir    Longest duration  or lente insulin. Impaired absorption of insulin may occur
                                                   of effect     as a result of thickening of the skin and inflammation of the
                             Insulin glargine
  VetBooks.ir                Protamine zinc                      subcutaneous tissues caused by chronic injection of insulin
                                                                 in the same area of the body. Rotation of the injection site
                                                                 will help prevent this problem.
                                Lente
                                                                   Allergic reactions to insulin
                                NPH                                Allergic reactions to insulin have been poorly docu-
                                                                 mented  in diabetic  dogs. Pain on  injection  of insulin is
                              70% NPH,
                          30% regular crystalline                usually caused by inappropriate injection technique, inap-
                                                                 propriate site of injection, a reaction to the cold temperature
                              50% NPH,                           of insulin stored in the refrigerator, the acidic pH of insulin
                          50% regular crystalline
                                                                 glargine, or issues with behavior and not an adverse reaction
                           Regular crystalline                   to insulin, per se. Chronic injection of insulin in the same
                                                Shortest duration  area of the body may cause inflammation and thickening of
            More potent    Insulin lyspro, aspart  of effect
                                                                 the skin and subcutaneous tissues, and may be caused by an
            FIG 49.11                                            immune reaction to insulin or some other protein (e.g., prot-
            Categorization of types of commercial insulin based on   amine) in the insulin bottle. Inflammation and thickening of
            potency and duration of effect. An inverse relationship exists   the skin and subcutaneous tissues may impair insulin
            between potency and duration of effect.              absorption, resulting in recurrence of clinical signs of diabe-
                                                                 tes. Rarely, diabetic dogs will develop acute focal subcutane-
                                                                 ous edema and swelling at the site of an insulin injection.
            administration creates problems with hypoglycemia and   Insulin allergy is suspected in these animals. Treatment
            glucose counterregulation. In these dogs the glucose nadir   includes switching to a less antigenic insulin and to a more
            after the morning administration of insulin typically occurs   purified insulin preparation. Systemic allergic reactions to
            near or after the time of the evening insulin administration,   insulin in dogs have yet to be identified.
            and the morning blood glucose concentration is usually   Concurrent disorders causing insulin resistance
            greater than 300 mg/dL (see Fig. 49.8). Gradually decreasing   Insulin resistance is a condition in which a normal
            blood glucose concentrations measured at the time of   amount of insulin produces a subnormal biologic response.
            sequential insulin injections is another indication of pro-  Insulin  resistance  may  result  from problems occurring
            longed insulin effect. The effectiveness of insulin in lowering   before the interaction of insulin with its receptor, at the
            the blood glucose concentration is variable from day to day,   receptor, or at steps distal to the interaction of insulin and
            presumably because of varying concentrations of diabeto-  its receptor. In dogs, receptor and postreceptor abnormalities
            genic hormones, the secretion of which was induced by prior   are  usually  attributable  to  obesity,  circulating  acute  phase
            hypoglycemia. Serum fructosamine concentrations are vari-  proteins and inflammatory cytokines (e.g., tumor necrosis
            able but usually greater than 500 µmol/L. An effective treat-  factor [TNF]-α, interleukin-1, interleukin-6) that interfere
            ment depends, in part, on the duration of effect of the insulin.   with insulin signal transduction or a disorder causing exces-
            An extended blood glucose curve should be generated after   sive or deficient secretion of an insulin-antagonistic hormone,
            administration of insulin once in the morning and feeding   such as cortisol, growth hormone, progesterone, or thyroid
            of the dog at normal times of the day. This will allow the   hormone. No insulin dose clearly defines insulin resistance.
            clinician to evaluate the effect of the evening meal on post-  For most diabetic dogs control of glycemia can usually be
            prandial blood glucose concentrations and to estimate   attained using 1.0 U or less of lente or NPH insulin per
            whether insulin from the morning injection is still present   kilogram of body weight given twice daily (see Table 49.4).
            in  the  blood  and  capable  of  preventing a  postprandial   Insulin resistance should be suspected if control of glycemia
            increase in blood glucose. If postprandial blood glucose   is poor despite an insulin dosage in excess of 1.5 U/kg, when
            increases (typically ≥ 75 mg/dL) within 2 hours of feeding,   excessive amounts of insulin (i.e., insulin dosage >1.5 U/kg)
            the duration of effect is close to 12 hours, and manipulation   are necessary to maintain the blood glucose concentration
            of the insulin dose, timing of the meals in relation to the   below 300 mg/dL), and when control of glycemia is erratic
            timing of insulin injections, or both should be tried before a   and insulin requirements are constantly changing in an
            switch is made to longer-acting insulin. Failure of the blood   attempt to maintain control of glycemia. Failure of the blood
            glucose to increase 2 hours or longer after the evening meal   glucose concentration to decrease below 300 mg/dL during
            is eaten suggests a prolonged duration of effect (i.e., 14 hours   a serial blood glucose curve is suggestive of, but not defini-
            or longer). Switching to a longer-acting insulin (e.g., insulin   tive for, the presence of insulin resistance. An insulin
            detemir) administered once a day can be tried initially (see   resistance–type blood glucose curve can also result from
            Fig. 49.11).                                         other problems with insulin therapy (see Box 49.8), and a
              Inadequate insulin absorption                      decrease in the blood glucose concentration below 300 mg/
              Slow or inadequate absorption of insulin from the subcu-  dL can occur with disorders causing relatively mild insulin
            taneous site is uncommon in diabetic dogs treated with NPH   resistance (e.g., obesity, inflammation). Serum fructosamine
   850   851   852   853   854   855   856   857   858   859   860